Home

Santen Pharmaceutical ADR (SNPHY)

9.9600
+0.4555 (4.79%)
OP · Last Trade: Apr 16th, 1:44 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close9.505
Open10.14
Bid-
Ask-
Day's Range9.390 - 10.15
52 Week Range8.650 - 13.00
Volume15,869
Market Cap-
PE Ratio (TTM)-
EPS (TTM)-
Dividend & YieldN/A (N/A)
1 Month Average Volume5,284

Chart

News & Press Releases

SNPHY Stock Earnings: Santen Pharmaceutical Reported Results for Q4 2023investorplace.com
Santen Pharmaceutical just reported results for the fourth quarter of 2023.
Via InvestorPlace · May 17, 2024
Current Analysis: Santen Pharmaceuticaltalkmarkets.com
Santen Pharmaceutical Co Ltd is a drug manufacturing company that focuses on ophthalmic products. Over the past year, Santen's share price rose about 32% from $7.60 to $10.01 as of Thursday’s market close
Via Talk Markets · February 15, 2024